Abyss Ingredients
Abyss Ingredients is a France-based B2B supplier of six proprietary marine bioactive ingredients (collagen, peptides, polyphenols, micronutrients) for nutraceutical, nutricosmetic, and functional food manufacturers, backed by 13 published studies and academic R&D partnerships.
- Company typePrivate
- Founded2004
- HeadquartersCaudan, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Abyss Ingredients does
Abyss Ingredients is a France-based B2B supplier of marine-derived bioactive ingredients for the nutraceutical, nutricosmetic, food, and feed industries. Founded in 2004 in Caudan (Brittany), the company upcycles fishing and marine co-products into six proprietary branded ingredients: Cartidyss (marine Type II collagen for beauty and joint health), Mnemosyss (marine peptides and omega-3 for cognitive health), Peptidyss (marine peptides for stress and sleep), Dermatidyss (marine peptides for atopic-prone skin), InSea2 (marine polyphenols from brown algae for glycemic control), and IodAID (marine micronutrients for general well-being). Its core technology rests on proprietary extraction and formulation know-how, supported by 13 published scientific studies and an ANR-selected joint laboratory (LabCom SeaMind) with NutriNeuro/INRAE including CIFRE PhD programs.
The business model is exclusively B2B, selling ingredients to dietary supplement and nutraceutical manufacturers for incorporation into finished consumer products; pricing is quote-based with no public disclosure. The company employs 20+ people (within the 11-50 band), with one-third of staff dedicated to R&D, generates 65% of revenue from export markets, and maintains an active international trade show presence across Europe, North America, and Asia. The 2019 arrival of GO Capital as investor and Alexis Mehaignerie as CEO marked a strategic shift toward clinically validated, high-efficacy ingredients, with subsequent product launches (Mnemosyss 2021, Dermatidyss 2023) and major collaborative R&D projects (BrainBooster €2.5M, Alg4Health €3.7M) funded by BPI France, ANR, Région Bretagne, and other public backers under the France 2030 framework.
Abyss Ingredients firmographics
Firmographics- Name
- Abyss Ingredients
- Legal name
- Abyss Ingrédients
- Website
- https://abyss-ingredients.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Abyss Ingredients is a France-based B2B supplier of six proprietary marine bioactive ingredients (collagen, peptides, polyphenols, micronutrients) for nutraceutical, nutricosmetic, and functional food manufacturers, backed by 13 published studies and academic R&D partnerships.
- Ownership category
- akta.pro rank
Abyss Ingredients industry classification
Industry- Product category
- Marine Nutraceutical Ingredients
- NAICS
- Food Manufacturing (311)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates) (AFAJALAK)
- akta.pro secondary industries
- Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF), Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH)
Keywords
Where Abyss Ingredients is headquartered
LocationHeadquarters
- HQ city
- Caudan
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Abyss Ingredients business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales
Revenue model
- B2B Marine Ingredient Sales: Sale of proprietary marine bioactive ingredients to dietary supplement and nutraceutical manufacturers. Ingredients are sold as functional components for integration into final consumer products targeting cognitive health, beauty, joint health, stress management, and metabolic health.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Abyss Ingredients product offering
Product offeringCore offering
Abyss Ingredients develops and supplies proprietary marine bioactive ingredients derived from fishing co-products for B2B clients in the nutraceutical, nutricosmetic, food, and feed industries. Its product portfolio covers six branded actives targeting cognitive health, joint and beauty health, stress and sleep, atopic-prone skin, glycemic control, and general well-being. Ingredients are sold as functional components for integration by dietary supplement and nutraceutical manufacturers into finished consumer products.
Product overview
Abyss Ingredients offers a portfolio of 6 marine ingredient products for the nutraceutical and nutricosmetic markets. The product line includes: Cartidyss (marine Type II collagen for beauty and joint health), Mnemosyss (marine peptides and omega 3 for cognitive health), Peptidyss (marine peptides for stress and sleep), Dermatidyss (marine peptides for atopic skin), InSea2 (marine polyphenols for glycemic control), and IodAID (marine micronutrients for general well-being). These ingredients target various health segments including cognitive health, skin beauty, dermoceutics, joint comfort, stress/sleep management, and cardiovascular health. The company operates as a B2B ingredient supplier, providing these scientifically validated marine-derived actives to manufacturers of dietary supplements and functional foods.
Differentiator
Problem solved
Functional benefit
Brands
- Cartidyss: Marine collagen Type II for beauty and joint health
- Mnemosyss
- Peptidyss
- Dermatidyss
- InSea2
- IodAID
Products and services
- Cartidyss Marine Type II collagen ingredient containing collagen peptides and glycosaminoglycans (GAGs) sourced from marine cartilage, designed for B2B manufacturers of dietary supplements targeting beauty from within and joint health.
- Mnemosyss Marine peptides and omega-3 ingredient for age-related cognitive decline and cognitive health, scientifically and clinically validated for B2B dietary supplement manufacturers.
- Peptidyss Marine bioactive peptide ingredient for stress and sleep management, designed for B2B manufacturers of stress and sleep dietary supplements.
- Dermatidyss Marine peptide ingredient combining anti-stress peptides, collagen peptides, and glycosaminoglycans, formulated for B2B nutricosmetic and dermo-cosmetic manufacturers targeting atopic-prone skin comfort.
- InSea2 Marine polyphenol ingredient sourced from brown algae extracts, clinically validated for glycemic control and metabolic health and supplied to B2B nutraceutical manufacturers.
- IodAID Iodine-based marine micronutrient ingredient for general well-being, supplied to B2B nutraceutical manufacturers for use in dietary supplement formulations.
Quantifiable outcome
- First effects felt from Dermatidyss within 11 days
Companies that use Abyss Ingredients
Customer profileSegments1 record
Ideal customer profiles1 record
Abyss Ingredients technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Abyss Ingredients partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- innovActivminorCommercial partnership strengthened in April 2023. Abyss distributes InSea2 and IodAID ingredients through this partnership, expanding product offerings with marine-based ingredients.
- NutriNeuro (University of Bordeaux)corePublic research laboratory specialized in nutrition and neuroscience. Partner in the LabCom SeaMind joint laboratory, selected by ANR (National Research Agency). Conducting collaborative research including CIFRE PhD programs on marine ingredients for cognitive health.
- INRAEcoreNational Research Institute for Agriculture, Food and Environment. Supervisory authority for NutriNeuro laboratory, involved in collaborative cognitive health research.
- Biotech Santé BretagneminorRegional biotech cluster serving as project facilitator and accompanist for healthcare and biotechnology innovation projects.
- ValorialminorFood innovation cluster that co-labels and supports collaborative projects including Alg4Health and BrainBooster.
- Agri Sud-Ouest InnovationminorAgricultural innovation cluster co-labelling the Alg4Health collaborative project.
- Pôle Mer Bretagne AtlantiqueminorMarine industry cluster co-labelling BrainBooster and VIPP projects.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Abyss Ingredients competitors and assessment
Company assessmentDirect peers
- Aker BioMarine: Aker BioMarine is a Norwegian biotech company specializing in krill-derived omega-3 (Superba) and marine ingredients for human nutrition and pet food. Highly comparable to Abyss Ingredients given the shared focus on scientifically validated marine bioactive ingredients sold B2B to supplement manufacturers.
- Hofseth BioCare: Hofseth BioCare is a Norwegian company that upcycles salmon co-products into premium ingredients including marine collagen peptides, omega-3 oils, and protein hydrolysates for nutraceuticals. Directly comparable to Abyss's circular-economy model of converting fishing industry co-products into health ingredients.
- Rousselot: Rousselot (part of Darling Ingredients) is a global leader in collagen peptides including its Peptan marine collagen range for joint, bone, skin, and muscle health. Directly competes with Cartidyss in the marine collagen peptide segment for nutraceutical applications.
- GELITA: GELITA is a German-based global leader in collagen peptides with marine (FISH COLLAGEN PEPTIDES) and bovine offerings for the supplement industry. Comparable as a B2B marine bioactive peptide supplier with strong scientific substantiation, though at significantly larger scale.
- Weishardt: Weishardt is a French company (like Abyss) specializing in marine collagen and gelatin for nutraceutical, food, and cosmetics applications. Direct peer with similar geographic origin and marine collagen focus, serving overlapping B2B customer segments.
- Bioiberica: Bioiberica is a Spanish life sciences company producing bioactive ingredients for joint health (including marine-sourced options), mobility, and animal health. Comparable as a specialty ingredient supplier targeting musculoskeletal health, directly overlapping with Cartidyss's positioning.
- Marinova: Marinova is an Australian company specializing in fucoidan and polyphenol extracts from brown and red seaweeds for nutraceutical and cosmetic applications. Directly comparable to InSea2 given both companies extract marine polyphenols from brown algae for blood sugar, metabolic, and immune health.
Emerging players
- Algatechnologies (Solabia Group): Algatechnologies (now part of Solabia Group) produces astaxanthin and other microalgae-based bioactive ingredients for nutraceuticals and cosmetics. Comparable in algae-based ingredient sourcing for premium nutraceutical markets, with broader portfolio across algae-derived actives.
Broad incumbents
- Gnosis by Lesaffre: Gnosis by Lesaffre is the life sciences arm of Lesaffre, producing specialty nutritional ingredients including probiotics, vitamins, and yeast-based bioactives for supplement manufacturers. Broader incumbent in the B2B nutraceutical ingredient space with overlapping customer base.
- Seppic (Air Liquide Healthcare): Seppic is a subsidiary of Air Liquide that develops specialty ingredients including marine-derived excipients and bioactives for nutraceutical, cosmetic, and pharmaceutical applications. Larger incumbent with broader portfolio but overlapping in marine-sourced functional ingredients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Abyss Ingredients social profiles
Digital presenceAbyss Ingredients financial estimates
Financial estimateRevenue estimate
Valuation estimate
Abyss Ingredients leadership team
Management profileNumber of profiles
Profiles1 record
Abyss Ingredients funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Abyss Ingredients M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Abyss Ingredients
What does Abyss Ingredients do?
Abyss Ingredients develops and supplies proprietary marine bioactive ingredients derived from fishing co-products for B2B clients in the nutraceutical, nutricosmetic, food, and feed industries. Its product portfolio covers six branded actives targeting cognitive health, joint and beauty health, stress and sleep, atopic-prone skin, glycemic control, and general well-being. Ingredients are sold as functional components for integration by dietary supplement and nutraceutical manufacturers into finished consumer products.
Is Abyss Ingredients a public or private company?
Abyss Ingredients is a private company. It is classified as venture growth investor backed and is currently operating.
When was Abyss Ingredients founded?
Abyss Ingredients was founded in 2004. It employs 11 to 50 people.
Where is Abyss Ingredients based?
Abyss Ingredients is headquartered in Caudan, France, in the Europe region.
How does Abyss Ingredients make money?
One revenue line is on record: B2B Marine Ingredient Sales.
Who are Abyss Ingredients's main competitors?
Direct peers on record are Aker BioMarine, Hofseth BioCare, Rousselot, GELITA, Weishardt, Bioiberica and Marinova. Algatechnologies (Solabia Group) is listed as an emerging player. Broad incumbents are Gnosis by Lesaffre and Seppic (Air Liquide Healthcare).
Does Abyss Ingredients have an API?
No public API is recorded for Abyss Ingredients.
What industry is Abyss Ingredients in?
Abyss Ingredients's product category is Marine Nutraceutical Ingredients. Its primary akta.pro industry code is AFAJALAK, Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates), with a secondary code of AFAJAHAF, Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae). Its NAICS code is 311 and its SIC code is 2000.